Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Important overview of 35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation from the Intergroupe Francophone du Myélome (IFM) experience.”
Title: 35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience
Authors: Philippe Moreau, Cyrille Hulin, Alexis Talbot, Hélène Demarquette, Léo Caillot, Thomas Chalopin, Arthur Bobin, Salomon Manier, Xavier Leleu, Lionel Karlin, Denis Caillot, Cécile Sonntag, Pierre Feugier, Murielle Roussel, Romain Gounot, Margaret Macro, Mohamad Mohty, Laurent Garderet, Mourab Tiab, Frédérique Orsini-Piocelle, Laure Vincent, Nathalie Meuleman, Jean Fontan, Lidia Montes, Marie-Christiane Vekemans, Martine Escoffre-Barbe, Jean-Richard Eveillard, Jean-Marc Schiano de Colella, Jérôme Lambert, Jean-Yves Mary, Jean-Paul Fermand, Bertrand Arnulf, Jill Corre, Hervé Avet-Loiseau, Thierry Facon, Jean-Luc Harousseau, Cyrille Touzeau, Aurore Perrot
You can read the Full Article in Blood Cancer Journal.
You can find more posts featuring Robert Orlowski on OncoDaily.
